Nesiritide use for critically ill children awaiting cardiac transplantation

Pediatric Cardiology

Volumn 27, Issue 1, 2006, Pages 47-50

  Sehra, R ^a   Underwood, K ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cardiac dysfunction; Intravenous therapy; Pediatrics; Vasodilators

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

ARTICLE; BLOOD PRESSURE; CONGESTIVE HEART FAILURE; DIURESIS; DRUG EFFECT; FEMALE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MALE; NATRIURESIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

BLOOD PRESSURE; CRITICAL CARE; DIURESIS; FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; MALE; NATRIURESIS; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WAITING LISTS;

EID: 33745863342     PISSN: 01720643     EISSN: 14321971     Source Type: Journal    
DOI: 10.1007/s00246-005-0984-6     Document Type: Article

References (12)

1. Bufler J, Emerman C, Peacock WF, Mathur VS, Young JB: (2004) on behalf of the VMAC Study Investigators: The efficacy and safety of B-type natriuretic peptide (nesiritide) in patients with renal insufficiency and acutely decompensated congestive heart failure. Nephrol Dial Transplant 19:391-399 (Pubitemid 38195989)
2. Emerman CL: (2002) Safety and efficacy of nesiritide for the treatment of decompensated heart failure. Rev Cardiovasc Med 3:(Suppl 4)S28-S34
3. Emerman CL, Peacock WF, Silver MA: (2003) on behalf of the PROACTION study group Nesiritide added to standard care results in favorable reductions in systolic blood pressure and heart rate compared to standard care alone [abstract 221]. J Card Fail 9:SupplS61
4. Gajarski RJ, Rosenblatt H, Frazier OH: (1998) Pediatric cardiac transplantation. In: Garson AJ, Bricker JT, Fisher DJ, Neish SR (eds), The science and practice of pediatric cardiology. Williams & Wilkins: Baltimore, pp . 2515-2540
5. Marshall J, Berkenbosch JW, Russo P, Tobias JD: (2004) Preliminary experience with nesiritide in the pediatric population. Intensive Care Med 19:164-170 (Pubitemid 44544707)
6. McBride BF, White CMI: (2003) Acute decompensated heart failure: A contemporary approach to pharmacotherapeutic management. Pharmacotherapy 23:997-1020 (Pubitemid 36904001)
7. Moazami N, Damiano RJ, Bailey MS, et al. : (2003) Nesiritide (BNP) in the management of postoperative cardiac patients. Ann Thorac Surg 75:1974-1976 (Pubitemid 36677259)
8. Morrow WR: (2000) Cardiomyopathy and heart transplantation in children. Curr Opin Cardiol 15:216-223
9. Ohuchi H, Takasugi H, Ohashi H, et al. : (2003) Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation 108:2368-2376 (Pubitemid 37413544)
10. Tann SM: (2003) B-natriuretic peptide improves hemodynamics and renal function in heart transplant patients immediately after surgery [abstract 257]. J Heart Lung Transplant 22:(Suppl)S157
11. Tann SM, Uber W, VanBakel AB, et al.: (2002) Nesiritide as an adjunct to the treatment of decompensated heart failure immediately after cardiac transplantation [poster 710]. Presented at the American Transplant Congress, Washington, DC, April 26-May 1
12. Witteles R, Matsuda K, Fowler M: (2003) Utility of prolonged B-type natriuretic peptide infusions in patients prior to heart transplantation [abstract 176]. Presented at the American Transplant Congress 2003, Washington, DC, June 1